+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Lumbar Degenerative Disc Disease Market by Treatment Type, Product, End User, Insurance Coverage, Age Group - Global Forecast to 2030- Product Image
Lumbar Degenerative Disc Disease Market by Treatment Type, Product, End User, Insurance Coverage, Age Group - Global Forecast to 2030- Product Image
Sale

Lumbar Degenerative Disc Disease Market by Treatment Type, Product, End User, Insurance Coverage, Age Group - Global Forecast to 2030

  • PDF Icon

    Report

  • 189 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5944537
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Lumbar Degenerative Disc Disease Market grew from USD 796.33 million in 2024 to USD 855.87 million in 2025. It is expected to continue growing at a CAGR of 7.20%, reaching USD 1.20 billion by 2030.

Understanding Lumbar Degenerative Disc Disease and Its Market Landscape

Lumbar degenerative disc disease represents a pivotal challenge within spinal health, affecting millions of individuals and placing a mounting burden on healthcare systems. Characterized by progressive deterioration of intervertebral discs in the lumbar region, this condition frequently manifests in chronic pain, reduced mobility, and diminished quality of life. As demographic trends shift towards aging populations, the prevalence of disc degeneration intensifies, prompting stakeholders across clinical, commercial, and policy domains to seek comprehensive solutions.

This report offers an authoritative executive summary of the current landscape, synthesizing clinical advancements, regulatory developments, and market drivers. By exploring both non surgical and surgical treatment modalities, alongside emerging product innovations, the analysis provides a multidimensional perspective. The objective is to equip decision makers with clear, actionable insights into evolving therapeutic pathways, competitive dynamics, and strategic imperatives required to navigate this rapidly changing environment.

Transformative Shifts Reshaping Treatment and Care Pathways

The treatment paradigm for lumbar degenerative disc disease is undergoing transformative shifts, driven by technological innovation, patient-centric care models, and evolving reimbursement frameworks. Minimally invasive procedures are gaining traction over traditional open surgeries, as providers pursue faster recovery times and reduced perioperative risks. Concurrently, the integration of orthobiologics-such as platelet rich plasma and stem cell therapies-is reshaping protocol development, elevating the potential for tissue regeneration and functional restoration.

On the payer front, value based care initiatives are incentivizing outcomes over procedure volume, compelling device manufacturers and service providers to demonstrate both clinical efficacy and cost efficiency. Digital health tools, including remote monitoring platforms and tele-rehabilitation programs, are further enhancing post-procedure oversight and long-term adherence. Regulatory agencies have responded with expedited pathways for breakthrough therapies, encouraging investment in next-generation implants and biologic procedures. Together, these shifts signal a move towards holistic, data-driven care pathways that prioritize patient satisfaction and measurable outcomes.

Assessing the Cumulative Impact of US Tariffs on 2025 Market Dynamics

In 2025, cumulative US tariffs have exerted significant influence on the supply chain dynamics underpinning spinal treatment solutions. The cost of imported spinal implants, specialized surgical instruments, and critical raw materials such as titanium alloys and synthetic polymers has increased, prompting manufacturers to reassess sourcing strategies. Organizations with diversified manufacturing footprints have mitigated some exposure, while others have faced margin pressures leading to price adjustments or renegotiated contracts with domestic suppliers.

Beyond direct material costs, the impact of tariffs has extended to logistical complexities, including longer lead times and increased warehousing expenses. Companies have responded by strengthening local partnerships, investing in nearshoring capabilities, and driving supply chain transparency to anticipate disruptions. Meanwhile, collaborative procurement models among hospital networks and ambulatory centers have emerged to leverage collective bargaining power. These adaptive measures underscore the resilience of industry players as they navigate trade policy shifts without compromising on quality or accessibility of care.

Key Segmentation Insights Driving Strategic Priorities

Segmentation across treatment type reveals distinct strategic imperatives for non surgical and surgical modalities. Non surgical interventions encompass interventional therapy, pharmaceutical management, and physical therapy protocols. Within interventional therapy, epidural steroid injections, facet joint injections, nerve blocks, and radiofrequency ablation each present unique opportunities for innovation in delivery systems and imaging guidance. Pharmaceutical approaches span corticosteroids, muscle relaxants, NSAIDs, and opioids, with heightened emphasis on reducing opioid dependency through novel analgesics. Physical therapy offerings, including exercise therapy, manual manipulation, and traction, continue to evolve through digital platforms and personalized regimens.

On the surgical front, disc replacement devices, minimally invasive techniques, and spinal fusion procedures delineate key growth areas. Minimally invasive therapy subdivides into endoscopic, microscopic, and percutaneous procedures, each requiring specialized instrumentation and navigation technologies. Spinal fusion approaches range from anterior to transforaminal fusion, supported by a spectrum of bone graft materials-namely allograft, autograft, and synthetic alternatives-and orthobiologics such as growth factors and stem cell applications. Spinal implants, including interbody fusion cages and pedicle screw systems, alongside surgical instruments, form a critical pillar of product innovation.

End user segmentation spans ambulatory surgery centers, clinics, and hospital settings, with hospitals further classified as general or specialty. Insurance coverage segments encompass private, public, and uninsured populations, shaping reimbursement landscapes and access to care. Age group stratification, covering individuals aged 18 to 44, 45 to 64, and 65 plus, informs targeted outreach and therapy customization. Each segmentation axis informs tailored strategies for market penetration and resource allocation.

Regional Market Patterns and Growth Trajectories

Regional analysis highlights divergent market behaviors across the Americas, Europe Middle East & Africa, and Asia-Pacific regions. In the Americas, advanced reimbursement frameworks and robust infrastructure support widespread adoption of high-end surgical solutions and interventional therapies. Latin American markets are gradually expanding access through telemedicine and localized training initiatives, although cost sensitivity remains a key barrier.

The Europe Middle East & Africa region demonstrates heterogeneity in regulatory pathways and payer models. Western Europe has established protocols for minimally invasive fusion and orthobiologics, while emerging markets in the Middle East and Africa are investing in physician education and hospital accreditation to elevate standards of care. Cross-border collaborations are facilitating technology transfer and shared clinical trials.

Asia-Pacific markets exhibit rapid expansion in domestic manufacturing capacity for spinal implants and biologics. Market players are forging joint ventures to navigate local regulatory landscapes, capitalize on lower production costs, and address surging demand from aging populations. Additionally, government initiatives supporting value based procurement have catalyzed pilot programs that integrate digital rehabilitation tools.

Competitive Landscape and Leading Industry Players

The competitive landscape is anchored by global medtech leaders, emerging specialized device manufacturers, and innovative biologics developers. Leading companies are investing heavily in R&D to launch next-generation disc replacement devices, bioactive graft materials, and smart surgical tools. Strategic partnerships between device and software providers are accelerating the deployment of intraoperative navigation and robotics systems.

Simultaneously, growth stage companies are differentiating through proprietary stem cell platforms and growth factor formulations aimed at enhancing disc regeneration. Mergers and acquisitions remain a prevalent tactic, enabling larger players to expand their product portfolios and amplify geographic reach. Market incumbents continue to refine service offerings through integrated care models that span diagnosis, treatment, and rehabilitation, reinforcing their positions as full-spectrum providers.

Actionable Recommendations for Market Leadership

Industry leaders should prioritize investment in minimally invasive and biologics platforms that align with payer incentives for reduced hospital stays and improved functional outcomes. Strengthening supply chain resilience through dual sourcing strategies and regional manufacturing partnerships will mitigate the impact of evolving trade policies. Embracing digital health ecosystems-comprising remote patient monitoring, tele-rehabilitation, and data analytics-can enhance patient engagement and support long-term adherence to treatment protocols.

Engaging proactively with payers and regulatory bodies to shape value based reimbursement models is essential. Collaborative research initiatives with academic and clinical institutions can validate novel therapies and differentiate product offerings. By adopting a patient-centric approach that integrates personalized rehabilitation plans and outcome tracking, organizations will foster loyalty and drive sustainable growth.

Rigorous Methodology Underpinning the Research

This research draws upon rigorous primary and secondary data gathering methodologies. Expert interviews with leading orthopedic surgeons, pain specialists, and healthcare executives provided qualitative insights into clinical decision making and market access strategies. Published literature, regulatory filings, and technical patents were systematically reviewed to map product pipelines and innovation trajectories.

Quantitative data analysis included demand sequencing across treatment settings and insurance categories, while supply chain assessments evaluated manufacturing footprints and logistics networks. Hypothesis testing and triangulation techniques ensured data integrity and minimized bias. The methodological framework was designed to deliver a comprehensive, balanced, and reproducible view of the lumbar degenerative disc disease landscape.

Concluding Perspectives on Future Opportunities

The landscape of lumbar degenerative disc disease treatment is on the cusp of significant innovation. As minimally invasive and regenerative therapies gain clinical validation, the market is poised for a new phase of growth driven by patient outcomes and cost efficiency. Regional markets will continue to diverge based on regulatory environments and investment priorities, creating both challenges and opportunities for market entry and expansion.

Companies that align their strategies with segmented patient needs, leverage digital integration, and engage collaboratively with payers will be best positioned to capture value. By remaining agile in response to policy shifts and technological breakthroughs, stakeholders can navigate complexity and unlock future opportunities in this dynamic field.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Treatment Type
    • Non Surgical
      • Interventional Therapy
        • Epidural Steroid Injection
        • Facet Joint Injection
        • Nerve Block
        • Radiofrequency Ablation
      • Pharmaceutical
        • Corticosteroids
        • Muscle Relaxants
        • Nsaids
        • Opioids
      • Physical Therapy
        • Exercise Therapy
        • Manual Therapy
        • Traction Therapy
    • Surgical
      • Disc Replacement
      • Minimally Invasive Therapy
        • Endoscopic Surgery
        • Microscopic Surgery
        • Percutaneous Procedures
      • Spinal Fusion
        • Anterior Fusion
        • Interbody Fusion
        • Lateral Fusion
        • Posterolateral Fusion
        • Transforaminal Fusion
  • Product
    • Bone Graft Material
      • Allograft
      • Autograft
      • Synthetic
    • Orthobiologics
      • Growth Factors
      • Platelet Rich Plasma
      • Stem Cell Therapies
    • Spinal Implants
      • Disc Replacement Devices
      • Interbody Fusion Cages
      • Pedicle Screw Systems
    • Surgical Instruments
  • End User
    • Ambulatory Surgery Center
    • Clinic
    • Hospital
      • General Hospital
      • Specialty Hospital
  • Insurance Coverage
    • Private Insurance
    • Public Insurance
    • Uninsured
  • Age Group
    • 18-44
    • 45-64
    • 65 Plus
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Medtronic plc
  • DePuy Synthes, Inc.
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • NuVasive, Inc.
  • Globus Medical, Inc.
  • Orthofix Medical Inc.
  • SeaSpine Holdings Corporation
  • RTI Surgical Holdings, Inc.
  • Alphatec Holdings, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Lumbar Degenerative Disc Disease Market, by Treatment Type
8.1. Introduction
8.2. Non Surgical
8.2.1. Interventional Therapy
8.2.1.1. Epidural Steroid Injection
8.2.1.2. Facet Joint Injection
8.2.1.3. Nerve Block
8.2.1.4. Radiofrequency Ablation
8.2.2. Pharmaceutical
8.2.2.1. Corticosteroids
8.2.2.2. Muscle Relaxants
8.2.2.3. Nsaids
8.2.2.4. Opioids
8.2.3. Physical Therapy
8.2.3.1. Exercise Therapy
8.2.3.2. Manual Therapy
8.2.3.3. Traction Therapy
8.3. Surgical
8.3.1. Disc Replacement
8.3.2. Minimally Invasive Therapy
8.3.2.1. Endoscopic Surgery
8.3.2.2. Microscopic Surgery
8.3.2.3. Percutaneous Procedures
8.3.3. Spinal Fusion
8.3.3.1. Anterior Fusion
8.3.3.2. Interbody Fusion
8.3.3.3. Lateral Fusion
8.3.3.4. Posterolateral Fusion
8.3.3.5. Transforaminal Fusion
9. Lumbar Degenerative Disc Disease Market, by Product
9.1. Introduction
9.2. Bone Graft Material
9.2.1. Allograft
9.2.2. Autograft
9.2.3. Synthetic
9.3. Orthobiologics
9.3.1. Growth Factors
9.3.2. Platelet Rich Plasma
9.3.3. Stem Cell Therapies
9.4. Spinal Implants
9.4.1. Disc Replacement Devices
9.4.2. Interbody Fusion Cages
9.4.3. Pedicle Screw Systems
9.5. Surgical Instruments
10. Lumbar Degenerative Disc Disease Market, by End User
10.1. Introduction
10.2. Ambulatory Surgery Center
10.3. Clinic
10.4. Hospital
10.4.1. General Hospital
10.4.2. Specialty Hospital
11. Lumbar Degenerative Disc Disease Market, by Insurance Coverage
11.1. Introduction
11.2. Private Insurance
11.3. Public Insurance
11.4. Uninsured
12. Lumbar Degenerative Disc Disease Market, by Age Group
12.1. Introduction
12.2. 18-44
12.3. 45-64
12.4. 65 Plus
13. Americas Lumbar Degenerative Disc Disease Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Lumbar Degenerative Disc Disease Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Lumbar Degenerative Disc Disease Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Medtronic plc
16.3.2. DePuy Synthes, Inc.
16.3.3. Stryker Corporation
16.3.4. Zimmer Biomet Holdings, Inc.
16.3.5. NuVasive, Inc.
16.3.6. Globus Medical, Inc.
16.3.7. Orthofix Medical Inc.
16.3.8. SeaSpine Holdings Corporation
16.3.9. RTI Surgical Holdings, Inc.
16.3.10. Alphatec Holdings, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. LUMBAR DEGENERATIVE DISC DISEASE MARKET MULTI-CURRENCY
FIGURE 2. LUMBAR DEGENERATIVE DISC DISEASE MARKET MULTI-LANGUAGE
FIGURE 3. LUMBAR DEGENERATIVE DISC DISEASE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 10. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INSURANCE COVERAGE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INSURANCE COVERAGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 16. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. LUMBAR DEGENERATIVE DISC DISEASE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. LUMBAR DEGENERATIVE DISC DISEASE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. LUMBAR DEGENERATIVE DISC DISEASE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY NON SURGICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INTERVENTIONAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY EPIDURAL STEROID INJECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY FACET JOINT INJECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY NERVE BLOCK, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY RADIOFREQUENCY ABLATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INTERVENTIONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY MUSCLE RELAXANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY NSAIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OPIOIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY EXERCISE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY MANUAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TRACTION THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY NON SURGICAL, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SURGICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY DISC REPLACEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY MINIMALLY INVASIVE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ENDOSCOPIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY MICROSCOPIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PERCUTANEOUS PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY MINIMALLY INVASIVE THERAPY, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL FUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ANTERIOR FUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INTERBODY FUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY LATERAL FUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY POSTEROLATERAL FUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TRANSFORAMINAL FUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY BONE GRAFT MATERIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ALLOGRAFT, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY AUTOGRAFT, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY BONE GRAFT MATERIAL, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ORTHOBIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY GROWTH FACTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PLATELET RICH PLASMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY STEM CELL THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ORTHOBIOLOGICS, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY DISC REPLACEMENT DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INTERBODY FUSION CAGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PEDICLE SCREW SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY AMBULATORY SURGERY CENTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY CLINIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY GENERAL HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPECIALTY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INSURANCE COVERAGE, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRIVATE INSURANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PUBLIC INSURANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY UNINSURED, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY 18-44, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY 45-64, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY 65 PLUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY NON SURGICAL, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INTERVENTIONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY MINIMALLY INVASIVE THERAPY, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY BONE GRAFT MATERIAL, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ORTHOBIOLOGICS, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INSURANCE COVERAGE, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY NON SURGICAL, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INTERVENTIONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY MINIMALLY INVASIVE THERAPY, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY BONE GRAFT MATERIAL, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ORTHOBIOLOGICS, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INSURANCE COVERAGE, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 107. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 108. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY NON SURGICAL, 2018-2030 (USD MILLION)
TABLE 109. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INTERVENTIONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 110. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 111. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 112. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 113. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY MINIMALLY INVASIVE THERAPY, 2018-2030 (USD MILLION)
TABLE 114. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 115. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 116. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY BONE GRAFT MATERIAL, 2018-2030 (USD MILLION)
TABLE 117. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ORTHOBIOLOGICS, 2018-2030 (USD MILLION)
TABLE 118. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 119. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 121. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INSURANCE COVERAGE, 2018-2030 (USD MILLION)
TABLE 122. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 123. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 124. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY NON SURGICAL, 2018-2030 (USD MILLION)
TABLE 125. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INTERVENTIONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 126. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 127. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 128. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 129. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY MINIMALLY INVASIVE THERAPY, 2018-2030 (USD MILLION)
TABLE 130. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 131. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 132. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY BONE GRAFT MATERIAL, 2018-2030 (USD MILLION)
TABLE 133. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ORTHOBIOLOGICS, 2018-2030 (USD MILLION)
TABLE 134. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 135. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 136. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 137. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INSURANCE COVERAGE, 2018-2030 (USD MILLION)
TABLE 138. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 139. BRAZIL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 140. BRAZIL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY NON SURGICAL, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INTERVENTIONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY MINIMALLY INVASIVE THERAPY, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 147. BRAZIL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY BONE GRAFT MATERIAL, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ORTHOBIOLOGICS, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 152. BRAZIL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 153. BRAZIL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INSURANCE COVERAGE, 2018-2030 (USD MILLION)
TABLE 154. BRAZIL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 155. ARGENTINA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 156. ARGENTINA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY NON SURGICAL, 2018-2030 (USD MILLION)
TABLE 157. ARGENTINA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INTERVENTIONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 158. ARGENTINA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 159. ARGENTINA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 160. ARGENTINA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 161. ARGENTINA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY MINIMALLY INVASIVE THERAPY, 2018-2030 (USD MILLION)
TABLE 162. ARGENTINA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 163. ARGENTINA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 164. ARGENTINA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY BONE GRAFT MATERIAL, 2018-2030 (USD MILLION)
TABLE 165. ARGENTINA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ORTHOBIOLOGICS, 2018-2030 (USD MILLION)
TABLE 166. ARGENTINA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 167. ARGENTINA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 168. ARGENTINA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 169. ARGENTINA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INSURANCE COVERAGE, 2018-2030 (USD MILLION)
TABLE 170. ARGENTINA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY NON SURGICAL, 2018-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INTERVENTIONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY MINIMALLY INVASIVE THERAPY, 2018-2030 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY BONE GRAFT MATERIAL, 2018-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ORTHOBIOLOGICS, 2018-2030 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INSURANCE COVERAGE, 2018-2030 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY NON SURGICAL, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INTERVENTIONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 192. UNITED KINGDOM LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 194. UNITED KINGDOM LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY MINIMALLY INVASIVE THERAPY, 2018-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 196. UNITED KINGDOM LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY BONE GRAFT MATERIAL, 2018-2030 (USD MILLION)
TABLE 198. UNITED KINGDOM LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ORTHOBIOLOGICS, 2018-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 200. UNITED KINGDOM LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 202. UNITED KINGDOM LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INSURANCE COVERAGE, 2018-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 204. GERMANY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 205. GERMANY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY NON SURGICAL, 2018-2030 (USD MILLION)
TABLE 206. GERMANY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INTERVENTIONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 207. GERMANY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 208. GERMANY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 209. GERMANY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 210. GERMANY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY MINIMALLY INVASIVE THERAPY, 2018-2030 (USD MILLION)
TABLE 211. GERMANY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 212. GERMANY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 213. GERMANY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY BONE GRAFT MATERIAL, 2018-2030 (USD MILLION)
TABLE 214. GERMANY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ORTHOBIOLOGICS, 2018-2030 (USD MILLION)
TABLE 215. GERMANY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 216. GERMANY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 217. GERMANY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 218. GERMANY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INSURANCE COVERAGE, 2018-2030 (USD MILLION)
TABLE 219. GERMANY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 220. FRANCE LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 221. FRANCE LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY NON SURGICAL, 2018-2030 (USD MILLION)
TABLE 222. FRANCE LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INTERVENTIONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 223. FRANCE LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 224. FRANCE LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 225. FRANCE LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 226. FRANCE LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY MINIMALLY INVASIVE THERAPY, 2018-2030 (USD MILLION)
TABLE 227. FRANCE LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 228. FRANCE LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 229. FRANCE LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY BONE GRAFT MATERIAL, 2018-2030 (USD MILLION)
TABLE 230. FRANCE LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ORTHOBIOLOGICS, 2018-2030 (USD MILLION)
TABLE 231. FRANCE LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 232. FRANCE LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. FRANCE LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 234. FRANCE LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INSURANCE COVERAGE, 2018-2030 (USD MILLION)
TABLE 235. FRANCE LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 236. RUSSIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 237. RUSSIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY NON SURGICAL, 2018-2030 (USD MILLION)
TABLE 238. RUSSIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INTERVENTIONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 239. RUSSIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 240. RUSSIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 241. RUSSIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 242. RUSSIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY MINIMALLY INVASIVE THERAPY, 2018-2030 (USD MILLION)
TABLE 243. RUSSIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 244. RUSSIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 245. RUSSIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY BONE GRAFT MATERIAL, 2018-2030 (USD MILLION)
TABLE 246. RUSSIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ORTHOBIOLOGICS, 2018-2030 (USD MILLION)
TABLE 247. RUSSIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 248. RUSSIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 249. RUSSIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 250. RUSSIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INSURANCE COVERAGE, 2018-2030 (USD MILLION)
TABLE 251. RUSSIA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 252. ITALY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 253. ITALY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY NON SURGICAL, 2018-2030 (USD MILLION)
TABLE 254. ITALY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INTERVENTIONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 255. ITALY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 256. ITALY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 257. ITALY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 258. ITALY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY MINIMALLY INVASIVE THERAPY, 2018-2030 (USD MILLION)
TABLE 259. ITALY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 260. ITALY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 261. ITALY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY BONE GRAFT MATERIAL, 2018-2030 (USD MILLION)
TABLE 262. ITALY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ORTHOBIOLOGICS, 2018-2030 (USD MILLION)
TABLE 263. ITALY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 264. ITALY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 265. ITALY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 266. ITALY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INSURANCE COVERAGE, 2018-2030 (USD MILLION)
TABLE 267. ITALY LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 268. SPAIN LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 269. SPAIN LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY NON SURGICAL, 2018-2030 (USD MILLION)
TABLE 270. SPAIN LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INTERVENTIONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 271. SPAIN LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 272. SPAIN LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 273. SPAIN LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 274. SPAIN LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY MINIMALLY INVASIVE THERAPY, 2018-2030 (USD MILLION)
TABLE 275. SPAIN LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 276. SPAIN LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 277. SPAIN LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY BONE GRAFT MATERIAL, 2018-2030 (USD MILLION)
TABLE 278. SPAIN LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ORTHOBIOLOGICS, 2018-2030 (USD MILLION)
TABLE 279. SPAIN LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL IMPLANTS, 2018-2030 (USD MILLION)
TABLE 280. SPAIN LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 281. SPAIN LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 282. SPAIN LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INSURANCE COVERAGE, 2018-2030 (USD MILLION)
TABLE 283. SPAIN LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY NON SURGICAL, 2018-2030 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INTERVENTIONAL THERAPY, 2018-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHYSICAL THERAPY, 2018-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY MINIMALLY INVASIVE THERAPY, 2018-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL FUSION, 2018-2030 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY BONE GRAFT MATERIAL, 2018-2030 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ORTHOBIOLOGICS, 2018-2030 (USD MILLION)
TABLE 295. UNITED ARAB EMIRATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE,

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Lumbar Degenerative Disc Disease market report include:
  • Medtronic plc
  • DePuy Synthes, Inc.
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • NuVasive, Inc.
  • Globus Medical, Inc.
  • Orthofix Medical Inc.
  • SeaSpine Holdings Corporation
  • RTI Surgical Holdings, Inc.
  • Alphatec Holdings, Inc.

Table Information

Report AttributeDetails
No. of Pages189
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 855.87 Million
Forecasted Market Value ( USD ) by 2030 $ 1200 Million
Compound Annual Growth Rate7.2%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Lumbar Degenerative Disc Disease Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F - Product Image

Lumbar Degenerative Disc Disease Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F

  • Report
  • 184 Pages
  • Global
From
Degenerative Disc Disease Market by Treatment Type, End User, Product Category, Distribution Channel, Device Type, Drug Class - Global Forecast to 2030 - Product Image

Degenerative Disc Disease Market by Treatment Type, End User, Product Category, Distribution Channel, Device Type, Drug Class - Global Forecast to 2030

  • Report
  • 190 Pages
  • Global
From
Degenerative Disc Disease Market 2024-2028 - Product Image

Degenerative Disc Disease Market 2024-2028

  • Report
  • 136 Pages
  • Global
From
Japan Lumbar Degenerative Disc Disease Market, By Region, Competition, Forecast & Opportunities, 2020-2030F - Product Image

Japan Lumbar Degenerative Disc Disease Market, By Region, Competition, Forecast & Opportunities, 2020-2030F

  • Report
  • 80 Pages
  • Japan
From
Degenerative Disc Disease Treatment Market Report 2025 - Product Image

Degenerative Disc Disease Treatment Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.